Progyny (NASDAQ: PGNY) reported Q4 EPS of $0.48, $0.34 better than the analyst estimate of $0.14. Revenue for the quarter came in at $318.4 million versus the consensus estimate of $306.06 million.

GUIDANCE:

Progyny sees FY2026 EPS of $1.83-$1.95, versus the consensus of $1.96. Progyny sees FY2026 revenue of $1.355-1.405 billion, versus the consensus of $1.393 billion.

Progyny sees Q1 2026 EPS of $0.42-$0.45, versus the consensus of $0.50. Progyny sees Q1 2026 revenue of $319-332 billion, versus the consensus of $343.9 billion.

For earnings history and earnings-related data on Progyny (PGNY) click here.